| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Raheja Manohar K. | EVP, Research & Development | C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK | /s/ Jeremy Hayden, Attorney-in-Fact for Manohar K. Raheja | 2025-05-21 | 0002042497 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGHT | Common Stock | Award | $38.5K | +12.8K | +8.24% | $3.02 | 168K | May 16, 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), that were acquired by the Reporting Person under the Sight Sciences, Inc. 2021 Employee Stock Purchase Plan ("2021 ESPP"). |
| F2 | Reflects the price at which the shares were acquired under the 2021 ESPP, which is equal to 85% of the fair market value of the Common Stock on the last day of the offering period under the 2021 ESPP. |